Cargando…

Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients

BACKGROUND: Combination anti-viral therapies have reduced treatment failure rates by requiring multiple specific mutations to be selected on the same viral genome to impart high-level drug resistance. To determine if the common protease inhibitor resistance mutation L90M is only selected once or rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Amit, Shapiro, Beth, Shafer, Robert W, Shulman, Nancy, Rhee, Soo-Yon, Delwart, Eric L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265302/
https://www.ncbi.nlm.nih.gov/pubmed/18221530
http://dx.doi.org/10.1186/1742-4690-5-7
_version_ 1782151468305874944
author Kapoor, Amit
Shapiro, Beth
Shafer, Robert W
Shulman, Nancy
Rhee, Soo-Yon
Delwart, Eric L
author_facet Kapoor, Amit
Shapiro, Beth
Shafer, Robert W
Shulman, Nancy
Rhee, Soo-Yon
Delwart, Eric L
author_sort Kapoor, Amit
collection PubMed
description BACKGROUND: Combination anti-viral therapies have reduced treatment failure rates by requiring multiple specific mutations to be selected on the same viral genome to impart high-level drug resistance. To determine if the common protease inhibitor resistance mutation L90M is only selected once or repeatedly on different HIV genetic backbones during the course of failed anti-viral therapies we analyzed a linked region of the viral genome during the evolution of multi-drug resistance. RESULTS: Using L90M allele specific PCR we amplified and sequenced gag-pro regions linked to very early L90M containing HIV variants prior to their emergence and detection as dominant viruses in 15 failed salvage therapy patients. The early minority L90M linked sequences were then compared to those of the later L90M viruses that came to dominate the plasma quasispecies. Using Bayesian evolutionary analysis sampling trees the emergence of L90M containing viruses was seen to take place on multiple occasion in 5 patients, only once for 2 patients and an undetermined number of time for the remaining 8 patients. CONCLUSION: These results indicate that early L90M mutants can frequently be displaced by viruses carrying independently selected L90M mutations rather than by descendents of the earlier mutants.
format Text
id pubmed-2265302
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22653022008-03-07 Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients Kapoor, Amit Shapiro, Beth Shafer, Robert W Shulman, Nancy Rhee, Soo-Yon Delwart, Eric L Retrovirology Research BACKGROUND: Combination anti-viral therapies have reduced treatment failure rates by requiring multiple specific mutations to be selected on the same viral genome to impart high-level drug resistance. To determine if the common protease inhibitor resistance mutation L90M is only selected once or repeatedly on different HIV genetic backbones during the course of failed anti-viral therapies we analyzed a linked region of the viral genome during the evolution of multi-drug resistance. RESULTS: Using L90M allele specific PCR we amplified and sequenced gag-pro regions linked to very early L90M containing HIV variants prior to their emergence and detection as dominant viruses in 15 failed salvage therapy patients. The early minority L90M linked sequences were then compared to those of the later L90M viruses that came to dominate the plasma quasispecies. Using Bayesian evolutionary analysis sampling trees the emergence of L90M containing viruses was seen to take place on multiple occasion in 5 patients, only once for 2 patients and an undetermined number of time for the remaining 8 patients. CONCLUSION: These results indicate that early L90M mutants can frequently be displaced by viruses carrying independently selected L90M mutations rather than by descendents of the earlier mutants. BioMed Central 2008-01-25 /pmc/articles/PMC2265302/ /pubmed/18221530 http://dx.doi.org/10.1186/1742-4690-5-7 Text en Copyright © 2008 Kapoor et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kapoor, Amit
Shapiro, Beth
Shafer, Robert W
Shulman, Nancy
Rhee, Soo-Yon
Delwart, Eric L
Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
title Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
title_full Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
title_fullStr Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
title_full_unstemmed Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
title_short Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
title_sort multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265302/
https://www.ncbi.nlm.nih.gov/pubmed/18221530
http://dx.doi.org/10.1186/1742-4690-5-7
work_keys_str_mv AT kapooramit multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients
AT shapirobeth multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients
AT shaferrobertw multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients
AT shulmannancy multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients
AT rheesooyon multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients
AT delwartericl multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients